CRISPR-driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges

Area of Science:

• Molecular Biology
• Biotechnology
• Infectious Disease Diagnostics

Background:

• Pathogen infections pose significant public health risks, necessitating rapid and accurate diagnostic methods.
• Effective disease diagnosis is crucial for timely treatment and epidemiological surveillance.
• Current diagnostic tools require improvement in speed, sensitivity, and accessibility.

Purpose of the Study:

• To review recent advancements in CRISPR/Cas systems for nucleic acid detection.
• To analyze the molecular mechanisms and clinical efficacy of CRISPR-Cas9, CRISPR-Cas12, and CRISPR-Cas13.
• To explore innovations and challenges in translating CRISPR diagnostics for public health.

Main Methods:

• Review of current research on CRISPR/Cas systems (Cas9, Cas12, Cas13) for nucleic acid detection.
• Analysis of CRISPR-based nucleic acid detection mechanisms, including crRNA-guided targeting and trans-cleavage.
• Comparison of CRISPR diagnostics with traditional methods regarding speed, sensitivity, and cost.

Main Results:

• CRISPR/Cas systems enable ultra-sensitive (aM level) and specific pathogen identification.
• CRISPR diagnostics demonstrate superior performance over traditional methods, suitable for point-of-care applications.
• Key innovations include amplification-free detection, portable devices, and multiplex platforms.

Conclusions:

• CRISPR diagnostics show promise for revolutionizing infectious disease detection and management.
• Overcoming challenges in clinical adoption, scalability, and regulation is essential for widespread implementation.
• Future directions involve integrated systems, AI, and addressing biosafety and ethical considerations for global health equity.